Chemical/Biological Technologies FY2017 Program Build DTRA BAA

Closed Solicitation Posted

Solicitation number
HDTRA1-17-S-0001
Agency
Defense Threat Reduction Agency Department of Defense
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
541711 Research and Development in Biotechnology
PSC
Not on record

Notice details come from SAM.gov. Updated .

About this opportunity

This Broad Agency Announcement from the Defense Threat Reduction Agency solicits proposals to support the Chemical and Biological Technologies Fiscal Year 2017 Program Build. Proposals are sought within nine technical areas, including detection of chemical and biological threats, information systems development, individual and collective protection, hazard mitigation, threat agent science, medical pre-treatments, diagnostics, therapeutics, and threat surveillance. Proposals must address one of the current topics presented and will be evaluated based on technical merit, transition potential to joint acquisition programs, and cost. The closing date for Phase I proposals is September 30, 2016, with Phase II invitations by November 17, 2016 and a closing date of December 23, 2016.

There is no set-aside designation specified. Potential areas of focus involve chemical and biological defense technologies. Estimated award dates range from March 2017 to August 2017 depending on complexity and available funding. Proposals may result in contracts, task orders, or other transaction agreements to be performed at locations to be determined and managed by the Defense Threat Reduction Agency in support of its mission goals.

Notice text

The purpose of this Broad Agency Announcement (BAA) is to solicit proposals for the Chemical and Biological Technologies (CBT) Fiscal Year (FY) 2017 Program Build. This solicitation is an extramural endeavor focused on seeking optimum approaches to meet technology objectives within the following areas: Detection - Chemical and Biological, Information Systems Capability Development, Protection - Individual and Collective, Hazard Mitigation, Threat Agent Science, Medical Pretreatments, Medical Diagnostics, Medical Therapeutics, and Threat Surveillance - Chemical and Biological. DTRA is seeking optimum approaches to meet technology objectives within the aforementioned areas, with a goal to identify and select science and technology projects that can be transitioned to joint acquisition programs. Proposals may only address the current topics presented within this BAA.
All questions related to this BAA must be e-mailed to Dtra.belvoir.J9.mbx.CB-BAA@mail.mil

Attachments

Files attached to this notice, newest first
File Type Posted
HDTRA1-17-S-0001_Conformed_Copy.pdf PDF
HDTRA1-17-S-0001_--_Amendment_2.pdf PDF
ATTACHMENT_4_-_Cost_Spreadsheet.xlsx XLSX spreadsheet
HDTRA1-17-S-0001_--_Amendment_1.pdf PDF
HDTRA1-17-S-0001_--_QA_-_Final.xlsx XLSX spreadsheet
ATTACHMENT_1_TRL_Definitions.pdf PDF
ATTACHMENT_5_-_Reps_and_Certs.pdf PDF
ATTACHMENT_3_-_SF1408.pdf PDF
ATTACHMENT_2_-_SOW_Template.pdf PDF
HDTRA1-17-S-0001.pdf PDF
ATTACHMENT_4_-_Cost_Spreadsheet.xlsx XLSX spreadsheet
ATTACHMENT_3_-_SF1408.docx DOCX document
ATTACHMENT_5_-_Reps_and_Certs.docx DOCX document
ATTACHMENT_2_-_SOW_Template.docx DOCX document
HDTRA1-17-S-0001.docx DOCX document
ATTACHMENT_1_TRL_Definitions.docx DOCX document
Show all 16

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity